'

IBM Watson Health extends partnership with US to help vets with cancer

After providing precision oncology care fore more than 2,700 veterans, the Department of Veterans Affairs and IBM are extending their partnership through at least June 2019.

IBM on Thursday said it's extending its partnership with the US Department of Veterans Affairs to apply artificial intelligence to cancer treatments for veterans.

The VA and IBM Watson Health first partnered to help cancer patients in 2016, as part of then-Vice President Joe Biden's cancer moonshot initiative. The partnership uses the Watson cognitive computing platform to help the VA's precision oncology department deliver individualized treatment plans.

Read also: Search ResultsIBM is the latest tech giant to extend parental leave - CNET

So far, the VA has used IBM Watson to help more than 2,700 veterans with cancer. They're extending the partnership through at least June 2019.

To prepare an individualized treatment plan, teams of scientists and clinicians must sequence a patient's DNA to pinpoint the likely cancer-causing mutations and determine what treatments would target those specific mutations. Using AI helps oncologists interpret the genomic data more quickly and easily.

IBM and the VA stressed how the partnership has focused largely on helping rural veterans with less access to cutting-edge cancer facilities. The VA established a hub in Durham, North Carolina where a small group of oncologists and pathologists have received tumor samples from patients nationwide. More than one-third of the patients treated by the VA's precision oncology program are Veterans from rural areas.

Read also: IBM Watson becomes an AI assistant for the enterprise - TechRepublic

"It is incredibly challenging to read, understand and stay up-to-date with the breadth and depth of medical literature and link them to relevant mutations for personalized cancer treatments," Dr. Kyu Rhee, chief health officer for IBM Watson Health, said in a statement. "This is where AI can play an important role in helping to scale precision oncology."

Watson, one of IBM's "strategic imperatives" was plagued by a report last year that it's costly hard for customers to implement. Then earlier this year, as IEEE reported, IBM laid off a percentage of its Watson Health workforce.

The latest financial report from IBM show less-than-stellar results from Watson: Big Blue's Q2 results show that revenue in its cognitive solutions division was effectively flat compared to a year ago. Still, the company continues to tout Watson as an area of growth:

Read also: IBM: still failing after all these years

"More clients are engaging IBM on their journey to the cloud, and deploying IBM Cloud, Watson AI, analytics, blockchain and security solutions," CEO Ginni Rometty said in a statement. "This demonstrates IBM's unique leadership in providing innovative technology coupled with deep industry expertise, trust and security."

Previous and related coverage:

Stronghold uses IBM blockchain for digital US dollar

IBM will explore uses of the Stronghold USD 'digital' coin on the IBM Blockchain Platform.

IBM seeks $167 million from Groupon in patent dispute

Groupon has been accused of using patented technology without permission -- despite Google, Amazon, and others paying for the privilege.